Evidence map›Paper›PMID 22039241›Full record

ArticleInvestigative ophthalmology & visual science2011

X-linked retinoschisis: RS1 mutation severity and age affect the ERG phenotype in a cohort of 68 affected male subjects.

Kristen Bowles, Catherine Cukras, Amy Turriff, Yuri Sergeev, Susan Vitale, Ronald A Bush, Paul A Sieving

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Understanding the phenotype of genetically associated electronegative ERG retinopathies: comparing the full-field ERG b:a ratio.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. X-Linked Retinoschisis.Cold Spring Harbor perspectives in medicine · 2023
    Review
  13. XLRS Rat with Rs1Genes · 2022
    Article
  14. Article
  15. Rs1hGene therapy · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kristen BowlesOphthalmic Genetics and Visual Function Branch, National Eye Institute, Bethesda, Maryland 20892, USA.
Catherine Cukras
Amy Turriff
Yuri Sergeev
Susan Vitale
Ronald A Bush
Paul A Sieving
National Eye Institute · USNational Institute on Deafness and Other Communication Disorders · US

Funding

Proteins From Hereditary Eye Diseases: In-silico and Experimental StudiesZIAEY000476 · NEI · NATIONAL EYE INSTITUTE · PI SERGEEV, YURI · 2009 to 2025
$16.8M
Preclinical and Clinical Development of Treatment for X-linked RetinoschisisZIADC000065 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI SIEVING, PAUL · 2009 to 2019
$5.7M
Retinal Degeneration--genetic/environmental animal modelZ01DC000065 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI SIEVING, PAUL · 2002 to 2008
$2.5M
CELLULAR AND MOLECULAR NEUROSCIENCE OF SURGERY SYSTEMST32DC000065 · NIDCD · UNIVERSITY OF KENTUCKY · PI GETCHELL, THOMAS V · 2001 to 2005
$711k
Intramural NIH HHS Z01 DC000065NIDCD NIH HHS DC000065-08NIDCD NIH HHS T32 DC000065
6 · The paper itself

Abstract

purposeTo assess the effect of age and RS1 mutation on the phenotype of X-linked retinoschisis (XLRS) subjects using the clinical electroretinogram (ERG) in a cross-sectional analysis.

methodsSixty-eight XLRS males 4.5 to 55 years of age underwent genotyping, and the retinoschisis (RS1) mutations were classified as less severe (27 subjects) or more severe (41 subjects) based on the putative impact on the protein. ERG parameters of retinal function were analyzed by putative mutation severity with age as a continuous variable.

resultsThe a-wave amplitude remained greater than the lower limit of normal (mean, -2 SD) for 72% of XLRS males and correlated with neither age nor mutation class. However, b-wave and b/a-ratio amplitudes were significantly lower in the more severe than in the less severe mutation groups and in older than in younger subjects. Subjects up to 10 years of age with more severe RS1 mutations had significantly greater b-wave amplitudes and faster a-wave trough implicit times than older subjects in this group.

conclusionsRS1 mutation putative severity and age both had significant effects on retinal function in XLRS only in the severe mutation group, as judged by ERG analysis of the b-wave amplitude and the b/a-ratio, whereas the a-wave amplitude remained normal in most. A new observation was that increasing age (limited to those aged 55 and younger) caused a significant delay in XLRS b-wave onset (i.e., a-wave implicit time), even for those who retained considerable b-wave amplitudes. The delayed b-wave onset suggested that dysfunction of the photoreceptor synapse or of bipolar cells increases with age of XLRS subjects.

Indexed as

ElectroretinographyMutationAdolescentAdultAge FactorsChildChild, PreschoolCross-Sectional StudiesEye ProteinsGenotypeHumansMaleMiddle AgedPhenotypeRetinaRetinoschisisEye ProteinsRS1 protein, human

Identifiers

PMID22039241
PMCPMC3302432
OpenAlexW2005629326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.